Samsung Biologics debuted last week in Seoul with the largest IPO in South Korea in years, according to the Associated Press.
During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives.
New York University has been awarded
Title: Assay plates, reader systems and methods for luminescence test measurements.
Patent Number: 8,808,627
Filed: Nov. 11, 2010
Siemens has been awarded
The Regents of the University of California have been awarded
Samsung has been awarded
Roche has been awarded
Samsung has been awarded US Patent No. 8,618,253, "Modified RNAse H and detection of nucleic acid amplification."
Win Den Chung and Jason Opdyke are named as inventors.
Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.
The New York Times Magazine examines gender discrimination at the Salk Institute.
Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.
A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.
In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.